New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2022, Updated recommendations on treatment of adolescents and children with chronic HCV infection: policy brief.
View latest version (2022)Bibliographic information
GuidelineGuidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
Year of Publication2018
Issuing InstitutionWorld Health Organization
Recommendation
Retired
Originally developed
WHO recommends the use of pangenotypic direct-acting antiviral regimens for the treatment of persons with chronic HCV infection aged 18 years and above
Recommended in favor
Conditional
Certainty of evidence
Moderate
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations
Year2022
InstitutionWHO